Before joining Clyra, Mr. Harrison served on the Board of Directors of BioLargo, Inc. as Chairman of the Audit & Compensation committees and was an advisor for and investor in several healthcare and consumer products companies. Mr. Harrison was founder and CEO of InTouch Communications, Inc., a Competitive Local Exchange Carrier (CLEC), providing residential and business telephone services within the state of California. Mr. Harrison also served as CEO of Resource Medical Group, Inc., a provider of healthcare management consultancy services as well as President of Harrison Medical Technologies, Inc., a developer and marketer of diagnostic tests in partnership with University of California, Los Angeles.
Dr. Tanya Rhodes
Prior to joining Clyra, Dr. Rhodes served as President and CEO of Rhodes & Associates, a provider of healthcare consulting services, whose services spanned across the R&D, regulatory compliance, clinical trial, manufacturing and business development processes. She previously served as CEO of Manukamed, a developer, manufacture and marketer of products for wound healing, repair and regeneration. Dr. Rhodes served as CTO for a start-up pharmaceutical company, NitroBiotherapeutics, a developer of novel biopharma compounds. Prior to her C-Level roles, Dr. Rhodes held various management positions, including time as VP of Innovation for Smith and Nephew.
Dr. Brock Liden
Dr. Liden is a Board Certified Doctor of Podiatric Medicine in private practice. He is recognized as one of the world’s foremost experts in wound care and diabetic limb salvage. Most recently, Dr. Liden developed the SkinDiscTM technology. He has also been involved in multiple successful product development programs, including the GraftJacket, PriMatrix, and the Endoform Collagen Matrix dressing. He was integrally involved with Endoform from early clinical work, through the CMS coverage policy, and sales and marketing of the product, ultimately growing it the number 2 top-selling product in the U.S. collagen dressing market in a period of five years. Dr. Liden is a graduate of Capital University, received his Medical Degree from Ohio College of Podiatric Medicine and completed his Residency at the Dayton VA Medical Center.
Before his role at Clyra, Mr, Brown was Co-Managing partner Scion Solutions LLC. Mr. Brown Spencer has spent over 35 years in the medical device industry as an account manager, sales trainer/technician, territory manager and distributor, including stints at Zimmer and Wright Medical. As a leading distributor, Mr. Brown developed one of the first mobile labs for on-site surgeon education. Mr. Brown was co-creator of the first-to-market ‘Value Priced Orthopedic Implant’ company, White Box Orthopedics, which was sold to Microport/Implant Partners. He has several patents currently being processed or in the final review with the patent office and was also co-designer of the FastCast off-loading Total Contact System, which was taken from concept to acquisition prior to launch in 18 months. Mr. Brown holds Bachelor of Science from Purdue University.
Director of Product Development
Dr. Bejarano is a researcher experienced in fundamental and applied research related to materials science, including biomaterials for regenerative medicine and multifunctional nanoparticles for controlled drug delivery. Julian has a Masters in Materials Engineering from the Universidad del Valle, Colombia and a Doctorate in Engineering Sciences with emphasis in Materials Science from the Universidad de Chile. Julian was a visiting researcher during his Ph.D. studies at the Institute of Biomaterials at the University of Erlangen-Nuremberg, Germany. Following his doctorate studies, Dr. Bejarano was a postdoctoral fellow at the Advanced Center for Chronic Diseases in Chile and Research Advisor of the Group of Polymer Engineering at the Universidad de Chile.